Crossmark

Can FDA-Approved Immunomodulatory Drugs be Repurposed/Repositioned to Alleviate Chronic Pain?

Published Online: 2021-05-26

Published Print: 2021-09

Authors

Inyang, Kufreobong E.

Folger, Joseph K.

Laumet, Geoffroy http://orcid.org/0000-0001-6752-3592
Funding

Funding for this research was provided by:

Rita Allen Foundation (Pain Scholar 2020)
License Information

Text and Data Mining valid from 2021-05-26

Version of Record valid from 2021-05-26
More Information

Article History

Received: 22 March 2021

Accepted: 18 May 2021

First Online: 26 May 2021

Declarations

:

: The authors declare no conflicts of interest.

Document is current